INB03 for the Treatment of Pulmonary Complications From COVID-19
Clinical trial NCT04370236 · TERMINATED
Trial details
- NCT number
- NCT04370236
- Sponsor
- Inmune Bio, Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-21
- Primary completion
- 2021-10-13
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.